Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
US7999011B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2003 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Mar 8, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a method of treating a patient having a tissue that is subject to an ischemic event. The method is conducted by parenterally administering a formulation containing a halogenated volatile anesthetic in an amount effective to improve the tissue's resistance to or tolerance of the ischemic event. In preferred embodiment of the invention, the amount of the formulation administered to the patient is sub-anesthetic. The formulation can be administered prior to, concurrently with, or after the ischemic event. The method can be used, for example, for treatment of patients having myocardial or neuronal tissue that is subject to an ischemic event.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.